EUVIMEDEUVIMED entdecken
Open Access

Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome

Han Sun, Yu Zhang, Jiahui Wang, Juncheng Su, Dejian Zhou, Xiang Yu, Yingjie Xu, Wen Yang

Theranostics · 2023 · 13 (14) · 4974-4992

DOI: 10.7150/thno.86466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Han Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong Univer…. Hauptthemen laut MEDLINE: Nanoparticles, Respiratory Distress Syndrome. Die Arbeit wurde bisher 26-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesRespiratory Distress SyndromeAnimalsMiceB7-H1 AntigenLungRecombinant ProteinsQuaternary Ammonium CompoundsFatty Acids, MonounsaturatedLiposomes

Stichwörter der Autor:innen

ARDSLNPsPD-L1immunosuppressionmRNA therapy

Substanzen

B7-H1 AntigenRecombinant Proteins1,2-dioleoyloxy-3-(trimethylammonium)propaneQuaternary Ammonium CompoundsFatty Acids, MonounsaturatedLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Department of Gastrointestinal Surgery, Renji Hospital Affiliated, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, 200433, China.
  • Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
  • Shanghai RNACure Biopharma Co., Ltd. Shanghai, 200438, China.
  • Shanghai Frontiers Science Center of Cellular Homeostasis and Human Diseases. Shanghai, 200025, China.

Zitieren

APA

Sun, H., Zhang, Y., Wang, J., Su, J., Zhou, D., Yu, X., Xu, Y., & Yang, W. (2023). Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome. Theranostics, 13(14), 4974-4992. https://doi.org/10.7150/thno.86466

Vancouver

Sun H, Zhang Y, Wang J, Su J, Zhou D, Yu X, et al. Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome. Theranostics. 2023;13(14):4974-4992. doi:10.7150/thno.86466

BibTeX
@article{Sun2023,
  author = {Sun, Han and Zhang, Yu and Wang, Jiahui and Su, Juncheng and Zhou, Dejian and Yu, Xiang and Xu, Yingjie and Yang, Wen},
  title = {Application of Lung-Targeted Lipid Nanoparticle-delivered mRNA of soluble PD-L1 via SORT Technology in Acute Respiratory Distress Syndrome},
  journal = {Theranostics},
  year = {2023},
  volume = {13},
  number = {14},
  pages = {4974--4992},
  doi = {10.7150/thno.86466}
}
Kostenlos starten →